Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Post-stroke mortality, stroke severity, and preadmission antipsychotic medicine use--a population-based cohort study.

Prior A, Laursen TM, Larsen KK, Johnsen SP, Christensen J, Andersen G, Vestergaard M.

PLoS One. 2014 Jan 8;9(1):e84103. doi: 10.1371/journal.pone.0084103. eCollection 2014.

2.

Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.

Gasse C, Jacobsen J, Pedersen L, Mortensen PB, Nørgaard M, Sørensen HT, Johnsen SP.

Pharmacotherapy. 2008 Jan;28(1):27-34.

PMID:
18154471
3.

Preadmission use of nonaspirin nonsteroidal anti-inflammatory drugs and 30-day stroke mortality.

Schmidt M, Hováth-Puhó E, Christiansen CF, Petersen KL, Bøtker HE, Sørensen HT.

Neurology. 2014 Nov 25;83(22):2013-22. doi: 10.1212/WNL.0000000000001024. Epub 2014 Nov 5.

PMID:
25378670
4.

Antipsychotic drugs and short-term mortality after peptic ulcer perforation: a population-based cohort study.

Christiansen C, Christensen S, Riis A, Thomsen RW, Johnsen SP, Tonnesen E, Sorensen HT.

Aliment Pharmacol Ther. 2008 Oct 1;28(7):895-902. doi: 10.1111/j.1365-2036.2008.03803.x. Epub 2008 Jul 11.

5.

Preadmission oral anticoagulant treatment and clinical outcome among patients hospitalized with acute stroke and atrial fibrillation: a nationwide study.

Johnsen SP, Svendsen ML, Hansen ML, Brandes A, Mehnert F, Husted SE.

Stroke. 2014 Jan;45(1):168-75. doi: 10.1161/STROKEAHA.113.001792. Epub 2013 Nov 26.

6.

Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.

Horsdal HT, Mehnert F, Rungby J, Johnsen SP.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):717-25. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.007. Epub 2011 May 4.

PMID:
21536457
7.

Preadmission Use of Glucocorticoids and 30-Day Mortality After Stroke.

Sundbøll J, Horváth-Puhó E, Schmidt M, Dekkers OM, Christiansen CF, Pedersen L, Bøtker HE, Sørensen HT.

Stroke. 2016 Mar;47(3):829-35. doi: 10.1161/STROKEAHA.115.012231. Epub 2016 Jan 28.

8.

Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke.

Sundbøll J, Schmidt M, Horváth-Puhó E, Christiansen CF, Pedersen L, Bøtker HE, Sørensen HT.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):748-54. doi: 10.1136/jnnp-2014-308948. Epub 2014 Sep 10.

PMID:
25209418
9.

Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients.

Barnett MJ, Perry PJ, Alexander B, Kaboli PJ.

J Clin Psychopharmacol. 2006 Apr;26(2):182-7.

PMID:
16633149
10.

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.

Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT.

Arch Intern Med. 2008 Oct 27;168(19):2081-7. doi: 10.1001/archinte.168.19.2081.

PMID:
18955636
11.

Risk of hospitalization for stroke associated with antipsychotic use in the elderly: a self-controlled case series.

Pratt NL, Roughead EE, Ramsay E, Salter A, Ryan P.

Drugs Aging. 2010 Nov 1;27(11):885-93. doi: 10.2165/11584490-000000000-00000.

PMID:
20964462
12.

Antipsychotics and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.

Nakagawa S, Pedersen L, Olsen ML, Mortensen PB, Sørensen HT, Johnsen SP.

J Intern Med. 2006 Nov;260(5):451-8.

13.

Effect of different antipsychotic drugs on short-term mortality in stroke patients.

Wang JY, Wang CY, Tan CH, Chao TT, Huang YS, Lee CC.

Medicine (Baltimore). 2014 Nov;93(25):e170. doi: 10.1097/MD.0000000000000170.

14.

Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.

Sundbøll J, Schmidt M, Horváth-Puhó E, Christiansen CF, Pedersen L, Bøtker HE, Sørensen HT.

BMC Neurol. 2015 Mar 7;15:24. doi: 10.1186/s12883-015-0279-3.

15.

Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.

Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.

J Ment Health Policy Econ. 2008 Jun;11(2):89-97.

PMID:
18509216
16.

Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.

Hsieh PH, Hsiao FY, Gau SS, Gau CS.

J Clin Psychopharmacol. 2013 Jun;33(3):299-305. doi: 10.1097/JCP.0b013e3182900dfe.

PMID:
23609396
17.

The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.

Kennedy J, Tien YY, Cohen LJ, Sclar DA, Liu D, Blodgett EG, Engle J.

Clin Ther. 2009 Dec;31(12):2931-9. doi: 10.1016/j.clinthera.2009.12.017.

PMID:
20110033
18.

Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Mehta S, Johnson ML, Chen H, Aparasu RR.

J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel.

PMID:
20573328
19.

Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.

Christensen S, Johansen MB, Tønnesen E, Larsson A, Pedersen L, Lemeshow S, Sørensen HT.

Crit Care. 2011;15(2):R87. doi: 10.1186/cc10085. Epub 2011 Mar 7.

20.

Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study.

O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Guyatt G, Gould L, D'Uva C, Kapral M, Silver F; Investigators of the Registry of the Canadian Stroke Network.

Lancet Neurol. 2006 Sep;5(9):749-54.

PMID:
16914403

Supplemental Content

Support Center